We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Sherwin-Williams
SHW
$82.7B
| $52.2M | 0.12% |
233,056
+31,150
| +15% | +$7.99M |
|
|
IMGN
177
DELISTED
Immunogen Inc
IMGN
| $52.1M | 0.12% |
11,586,193
| – | – |
|
|
SGEN
178
DELISTED
Seagen Inc. Common Stock
SGEN
| $52M | 0.12% |
+294,130
| New | +$42.4M |
|
179
Matador Resources
MTDR
$6.2B
| $51.8M | 0.12% |
1,112,776
+1,047,776
| +1,612% | +$56.9M |
|
180
Centene
CNC
$30.7B
| $51.5M | 0.12% |
609,112
-200
| -0% | -$16.6K |
|
181
American Electric Power
AEP
$69.6B
| $51.3M | 0.12% |
534,806
+8,900
| +2% | +$882K |
|
182
United Therapeutics
UTHR
$25.8B
| $50.7M | 0.12% |
215,000
-85,000
| -28% | -$17.3M |
|
183
Bio-Rad Laboratories Class A
BIO
$8.71B
| $50.5M | 0.12% |
102,075
+34,900
| +52% | +$18.2M |
|
184
Harmony Biosciences
HRMY
$2.04B
| $50.5M | 0.12% |
1,034,450
-97,766
| -9% | -$4.4M |
|
185
Phillips 66
PSX
$84.9B
| $50.1M | 0.11% |
611,001
-37,500
| -6% | -$3.47M |
|
186
Ally Financial
ALLY
$13.2B
| $50.1M | 0.11% |
1,494,801
-700,000
| -32% | -$28M |
|
187
Public Storage
PSA
$60.5B
| $49.7M | 0.11% |
158,992
-300
| -0.2% | -$104K |
|
188
Marriott International
MAR
$98.3B
| $49.6M | 0.11% |
364,825
+22,200
| +6% | +$3.67M |
|
189
Illinois Tool Works
ITW
$82.6B
| $49.4M | 0.11% |
271,182
+265,523
| +4,692% | +$53.1M |
|
190
McKesson
MCK
$100B
| $49.4M | 0.11% |
151,360
-5,100
| -3% | -$1.63M |
|
191
Newmont
NEM
$98.7B
| $49.3M | 0.11% |
826,500
-6,200
| -0.7% | -$439K |
|
|
DAWN
192
DELISTED
Day One Biopharmaceuticals
DAWN
| $49.2M | 0.11% |
2,746,825
+2,570,976
| +1,462% | +$26.5M |
|
193
Flywire
FLYW
$1.98B
| $49.2M | 0.11% |
2,788,211
+1,238,211
| +80% | +$28.8M |
|
|
IAA
194
DELISTED
IAA, Inc. Common Stock
IAA
| $49.2M | 0.11% |
1,500,000
+1,100,000
| +275% | +$40.3M |
|
195
Southern Company
SO
$109B
| $48.6M | 0.11% |
681,600
+124,900
| +22% | +$9.17M |
|
196
Duke Energy
DUK
$97.8B
| $48.4M | 0.11% |
451,813
-351,400
| -44% | -$38.6M |
|
197
General Motors
GM
$80.4B
| $48.2M | 0.11% |
1,518,486
+1,200
| +0.1% | +$45K |
|
198
General Mills
GIS
$19.1B
| $47.3M | 0.11% |
627,196
-2,700
| -0.4% | -$189K |
|
199
Travere Therapeutics
TVTX
$5.2B
| $47.2M | 0.11% |
1,950,000
+447,508
| +30% | +$11.3M |
|
200
Marathon Petroleum
MPC
$92.4B
| $46.3M | 0.11% |
563,460
-391,100
| -41% | -$36.6M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.